Risk factors for obesity in adult survivors of childhood cancer: A report from the childhood cancer survivor study

Journal of Clinical Oncology

Volumn 30, Issue 3, 2012, Pages 246-255

  Green, Daniel M ^a   Cox, Cheryl L ^a   Zhu, Liang ^a   Krull, Kevin R ^a   Srivastava, Deo Kumar ^a   Stovall, Marilyn ^b   Nolan, Vikki G ^f   Ness, Kirsten K ^f   Donaldson, Sarah S ^c   Oeffinger, Kevin C ^d   Meacham, Lillian R ^e   Sklar, Charles A ^d   Armstrong, Gregory T ^a   Robison, Leslie L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e EMORY UNIVERSITY   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER PAIN; CANCER SURVIVOR; CHILDHOOD CANCER; EDUCATIONAL STATUS; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; RADIATION DOSE; RISK FACTOR; SELF REPORT; SHORT FORM 36; STRUCTURAL EQUATION MODELING;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; LIFE STYLE; MALE; NEOPLASMS; OBESITY; RISK FACTORS; SURVIVORS; UNITED STATES; YOUNG ADULT;

EID: 84855989370     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.34.4267     Document Type: Article

References (56)

1. Meacham LR, Gurney JG, Mertens AC, et al: Body mass index in long-term adult survivors of childhood cancer: A report of the Childhood Cancer Survivor Study. Cancer 103:1730-1739, 2005 (Pubitemid 40490036)
2. Garmey EG, Liu Q, Sklar CA, et al: Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol 26:4639-4645, 2008
3. Zebrack BJ, Zeltzer LK, Whitton J, et al: Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma: A report from the Childhood Cancer Survivor Study. Pediatrics 110:42-52, 2002 (Pubitemid 34742639)
4. Zebrack BJ, Zevon MA, Turk N, et al: Psychological distress in long-term survivors of solid tumors diagnosed in childhood: A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 49:47-51, 2007 (Pubitemid 46847067)
5. Fava M, Judge R, Hoog SL, et al: Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment. J Clin Psychiatry 61:863-867, 2000
6. Aberg-Wistedt A, Agren H, Ekselius L, et al: Sertraline versus paroxetine in major depression: Clinical outcome after six months of continuous therapy. J Clin Psychopharmacol 20:645-652, 2000
7. Saddichha S, Ameen S, Akhtar S: Predictors of antipsychotic-induced weight gain in first-episode psychosis: Conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. J Clin Psychopharmacol 28:27-31, 2008
8. Safer DJ: A comparison of risperidone-induced weight gain across the age span. J Clin Psychopharmacol 24:429-436, 2004
9. Tran PV, Hamilton SH, Kuntz AJ, et al: Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 17:407-418, 1997 (Pubitemid 27414397)
10. Basson BR, Kinon BJ, Taylor CC, et al: Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62:231-238, 2001 (Pubitemid 32428761)
11. Bustillo JR, Buchanan RW, Irish D, et al: Differential effect of clozapine on weight: A controlled study. Am J Psychiatry 153:817-819, 1996 (Pubitemid 26170545)
12. Allison DB, Mentore JL, Heo M, et al: Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 156:1686-1696, 1999 (Pubitemid 29517559)
13. McQuade RD, Stock E, Marcus R, et al: A comparison of weight change during treatment with olanzapine or aripiprazole: Results from a randomized, double-blind study. J Clin Psychiatry 65:47-56, 2004
14. Kinon BJ, Lipkovich I, Edwards SB, et al: A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. J Clin Psychopharmacol 26:157-162, 2006 (Pubitemid 43740339)
15. Daniel DG, Zimbroff DL, Potkin SG, et al: Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial - Ziprasidone Study Group. Neuropsychopharmacology 20:491-505, 1999 (Pubitemid 29123876)
16. Arato M, O'Connor R, Meltzer HY: A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: The Ziprasidone Extended Use in Schizophrenia (ZEUS) study. Int Clin Psychopharmacol 17:207-215, 2002
17. Small JG, Hirsch SR, Arvanitis LA, et al: Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo Seroquel Study Group. Arch Gen Psychiatry 54:549-557, 1997 (Pubitemid 27258553)
18. Arvanitis LA, Miller BG: Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo - The Seroquel Trial 13 Study Group. Biol Psychiatry 42:233-246, 1997 (Pubitemid 27325811)
19. Verity CM, Hosking G, Easter DJ: A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy: The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol 37:97-108, 1995
20. Richens A, Davidson DL, Cartlidge NE, et al: A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy: Adult EPITEG Collaborative Group. J Neurol Neurosurg Psychiatry 57:682-687, 1994 (Pubitemid 24182951)
21. Mattson RH, Cramer JA, Collins JF: A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults: The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 327:765-771, 1992
22. Leisenring WM, Mertens AC, Armstrong GT, et al: Pediatric cancer survivorship research: Experience of the Childhood Cancer Survivor Study. J Clin Oncol 27:2319-2327, 2009
23. Robison LL, Mertens AC, Boice JD, et al: Study design and cohort characteristics of the childhood cancer survivor study: A multi-institutional collaborative project. Med Pediatr Oncol 38:229-239, 2002 (Pubitemid 34258414)
24. Robison LL, Armstrong GT, Boice JD, et al: The Childhood Cancer Survivor Study: A National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 27:2308-2318, 2009
25. Cox CL, Montgomery M, Oeffinger KC, et al: Promoting physical activity in childhood cancer survivors: Results from the Childhood Cancer Survivor Study. Cancer 115:642-654, 2009
26. Oeffinger KC, Mertens AC, Sklar CA, et al: Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol 21:1359-1365, 2003 (Pubitemid 46606416)
27. National Heart, Lung and Blood Institute Expert Panel on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. Bethesda, MD, National Institutes of Health, 1998
28. Osterkamp LK: Current perspective on assessment of human body proportions of relevance to amputees. J Am Diet Assoc 95:215-218, 1995
29. Packer RJ, Gurney JG, Punyko JA, et al: Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study. J Clin Oncol 21:3255-3261, 2003 (Pubitemid 46606258)
30. Green DM, Kawashima T, Stovall M, et al: Fertility of female survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 27:2677-2685, 2009
31. Stovall M, Donaldson SS, Weathers RE, et al: Genetic effects of radiotherapy for childhood cancer: Gonadal dose reconstruction. Int J Radiat Oncol Biol Phys 60:542-552, 2004 (Pubitemid 39233476)
32. Stovall M, Weathers R, Kasper C, et al: Dose reconstruction for therapeutic and diagnostic radiation exposures: Use in epidemiological studies. Radiat Res 166:141-157, 2006 (Pubitemid 44051207)
33. Physical Activity Guidelines Advisory Committee: Physical Activity Guidelines Advisory Committee Report, 2008. Washington, DC, Department of Health and Human Services, 2008
34. Zeltzer LK, Lu Q, Leisenring W, et al: Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: A report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 17:435-446, 2008 (Pubitemid 351272798)
35. Ware JE, Snow KK, Kosinski M. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI, Quality-Metric, 2000
36. Wacholder S: Binomial regression in GLIM: Estimating risk ratios and risk differences. Am J Epidemiol 123:174-184, 1986
37. Spiegelman D, Hertzmark E: Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162:199-200, 2005 (Pubitemid 41373523)
38. Stokes ME, Davis CS, Koch GG: Categorical data analysis using the SAS system. Cary, NC, SAS Institute, 1995
39. Derogatis LR: Brief Symptom Inventory (BSI) 18: Administration, scoring, and procedures manual. Minneapolis, MN, NCS Pearson, 2000
40. Recklitis CJ, Parsons SK, Shih MC, et al: Factor structure of the Brief Symptom Inventory-18 in adult survivors of childhood cancer: Results from the Childhood Cancer Survivor Study. Psychol Assess 18:22-32, 2006 (Pubitemid 43824258)
41. Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483, 1992
42. McHorney CA, Ware JEJ, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247-263, 1993
43. Browne M, Cudeck, R: Alternative ways of assessing model fit, in Bollen KA, Long JA (eds): Testing Structural Equation Models. Newbury Park, CA, Sage, 1993, pp 136-162
44. Hu L, Bentler P: Cutoff criteria for fit indices in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling 6:1-55, 1999
45. Bollen K: Overall fit in covariance structure models: Two types of sample size effects. Psychol Bull 107:256-259, 1990
46. Yu CY, Muthén BO: Evaluation of model fit indices for latent variable models with categorical and continuous outcomes. Los Angeles, CA, UCLA, Graduate School of Education and Information Studies, 2002
47. Muto R, Yamamori S, Ohashi H, et al: Prediction by FISH analysis of the occurrence of Wilms tumor in aniridia patients. Am J Med Genet 108:285-289, 2002 (Pubitemid 34225888)
48. Pischon T, Boeing H, Hoffmann K, et al: General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105-2120, 2008
49. Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006 (Pubitemid 44547808)
50. Woodwell DA, Cherry DK: National Ambulatory Medical Care Survey: 2002 Summary (Report No. 346). Hyattsville, MD, National Center for Health Statistics, 2004
51. Ness KK, Mertens AC, Hudson MM, et al: Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med 143:639-647, 2005
52. Arena VC, Padiyar KR, Burton WN, et al: The impact of body mass index on short-term disability in the workplace. J Occup Environ Med 48:1118-1124, 2006 (Pubitemid 44737082)
53. Guallar-Castillón P, Sagardui-Villamor J, Banegas JR, et al: Waist circumference as a predictor disability among older adults. Obesity 15:233-244, 2007 (Pubitemid 46219804)
54. Harkonmäki K, Korkeila K, Vahtera J, et al: Childhood adversities as a predictor of disability retirement. J Epidemiol Community Health 61:479-484, 2007 (Pubitemid 46799547)
55. McLaughlin KA, Borkovec TD, Sibrava NJ: The effects of worry and rumination on affect states and cognitive activity. Behav Ther 38:23-38, 2007 (Pubitemid 46209064)
56. Ness KK, Leisenring WM, Huang S, et al: Predictors of inactive lifestyle among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 115:1984-1994, 2009